Edit
Precision Medicine Group
https://www.precisionmedicinegrp.com/Last activity: 01.10.2024
Active
With the discipline of precision medicine as our foundation, Precision Medicine Group leverages specialized expertise to move science closer to health.
Location: United States, Maryland, Bethesda
Total raised: $275M
Investors 4
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| - | Oak Invest... | oakvc.com |
| - | TPG | tpg.com |
| - | Berkshire ... | berkshirep... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.12.2017 | - | $275M | - |
Mentions in press and media 17
| Date | Title | Description |
| 02.10.2024 | Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New Leadership | In the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag... |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | -- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors -- BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider... |
| 13.03.2023 | Precision Medicine Group Appoints John Hubbard, PhD, as Board of Directors Chair | BETHESDA, Md., March 13, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointment of John Hubbard, PhD, as Chairman of its Bo... |
| 12.11.2019 | Should employers take a chance on little-known Embarc to pay for gene therapy? | The promise of curing deadly diseases by administering a one-time therapy that rewrites a patient’s genetic code is no longer the stuff of science fiction. Yet this innovation comes with a steep price tag. Zolgensma, approved for spinal mus... |
| 08.11.2019 | Cambridge companies recognised at industry leading OBN Awards 2019 event | Cambridge companies recognised at industry leading OBN Awards 2019 event 08-11-2019 Cambridge Network members Bicycle Therapeutics and Endomag have been honoured at the 2019 OBN Awards, which celebrate the best of UK life sciences. OBN (UK)... |
| 24.04.2019 | Early treatment with gene therapy: lessons from vaccines | The concept of modifying the human genome to treat or cure disease was once the stuff of science fiction. Today there are products on the market to do just that. This amazing leap has come with a hefty price tag. Currently marketed gene the... |
| 22.08.2018 | CVS announcement of cost-effective benchmarks puts ICER in the spotlight | Last week’s announcement by CVS Health, which operates one of the country’s largest pharmacy benefit managers, is a harbinger of what may lie ahead for drug pricing and access in the United States. In what it called an effort to nudge drug ... |
| 10.01.2018 | Quartz Bio becomes part of Precision Medicine Group | |
| 28.12.2017 | Precision Medicine Group to Receive $275M Investment | Precision Medicine Group (PMG), a Bethesda, MD-based specialized services company supporting innovative approaches to drug development and commercialization, is to receive a $275m investment. The transaction is being led by Berkshire Partne... |
| 23.12.2017 | Precision Medicine Group Lands $275M | BETHESDA, MD, Precision Medicine Group (PMG) announced today that it has reached an agreement for a $275 million investment. >> Click here for more funding data on Precision Medicine Group >> To export Precision Medicine Gro... |
Show more